These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


71 related items for PubMed ID: 26782479

  • 21. miR-187 inhibits tumor growth and invasion by directly targeting MAPK12 in osteosarcoma.
    Cui C, Shi X.
    Exp Ther Med; 2017 Aug; 14(2):1045-1050. PubMed ID: 28810556
    [Abstract] [Full Text] [Related]

  • 22. MicroRNA-340 suppresses osteosarcoma tumor growth and metastasis by directly targeting ROCK1.
    Zhou X, Wei M, Wang W.
    Biochem Biophys Res Commun; 2013 Aug 09; 437(4):653-8. PubMed ID: 23872151
    [Abstract] [Full Text] [Related]

  • 23. Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma.
    Wang Z, Cai H, Lin L, Tang M, Cai H.
    Pediatr Blood Cancer; 2014 Feb 09; 61(2):206-10. PubMed ID: 24038809
    [Abstract] [Full Text] [Related]

  • 24. Clinical significance of microRNA-130b in osteosarcoma and in cell growth and invasion.
    Yu LD, Jin RL, Gu PC, Ling ZH, Lin XJ, Du JY.
    Asian Pac J Trop Med; 2015 Sep 09; 8(9):752-6. PubMed ID: 26433662
    [Abstract] [Full Text] [Related]

  • 25. MicroRNA-200b acts as a tumor suppressor in osteosarcoma via targeting ZEB1.
    Li Y, Zeng C, Tu M, Jiang W, Dai Z, Hu Y, Deng Z, Xiao W.
    Onco Targets Ther; 2016 Sep 09; 9():3101-11. PubMed ID: 27307751
    [Abstract] [Full Text] [Related]

  • 26. Regulatory role of microRNA184 in osteosarcoma cells.
    Yin GR, Wang Q, Zhang XB, Wang SJ.
    Genet Mol Res; 2015 Nov 13; 14(4):14246-52. PubMed ID: 26600482
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. MicroRNA-26b inhibits osteosarcoma cell migration and invasion by down-regulating PFKFB3 expression.
    Zheng WD, Zhou FL, Lin N.
    Genet Mol Res; 2015 Dec 14; 14(4):16872-9. PubMed ID: 26681033
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Mir-150 Up-Regulates Glut1 and Increases Glycolysis in Osteosarcoma Cells.
    Yuan G, Zhao Y, Wu D, Gao Ch.
    Asian Pac J Cancer Prev; 2017 Apr 01; 18(4):1127-1131. PubMed ID: 28547952
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The miR-17-92 cluster/QKI2/β-catenin axis promotes osteosarcoma progression.
    Yang H, Peng Z, Liang M, Zhang Y, Wang Y, Huang T, Jiang Y, Jiang B, Wang Y.
    Oncotarget; 2018 May 18; 9(38):25285-25293. PubMed ID: 29861871
    [Abstract] [Full Text] [Related]

  • 38. MicroRNA-638 expression change in osteosarcoma patients via PLD1 and VEGF expression.
    Xue M, Shen J, Cui J, Wu J, Qiao W, Ding N, Song C, Shan B.
    Exp Ther Med; 2019 May 18; 17(5):3899-3906. PubMed ID: 30988774
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 4.